Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BYPharmacology research & perspectives

Astragaloside IV and Ferroptosis Modulation in Pathological Cardiac Hypertrophy: Current Evidence, an Integrative Hypothesis, and Future Directions

  • Pengbo Liu1
  • Yongzhi Deng1
  1. 1The Affiliated Cardiovascular Hospital of Shanxi Medical University, Shanxi Cardiovascular Hospital (Institute), Shanxi Clinical Medical Research Center for Cardiovascular Disease
Read full textPDFCite

Related

  1. Astragaloside IV attenuates ferroptosis-related testicular injury in rats with experimental varicocele
    Boxian Gao, Shengjing Liu, Mengxin Sun +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefEurope PMC
  2. Low-valine diet ameliorates pathological cardiac hypertrophy by inhibiting LONP1-mediated degradation of ATP5F1B in male rodents
    Hongyu Kuang, Zhirou Zhang, Xinyu Wang +7
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  3. Cardiomyocyte-enriched OTUD5 alleviates pathological myocardial hypertrophy by deubiquitinating STAT3 and modulating the STAT3–PGC-1α axis
    Bozhi Ye, Yucheng Jiang, Zhaozheng Zheng +11
    Experimental & Molecular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
  4. Prometheus’s Fire, Part I: The Flight of Icarus—Molecular Mechanisms Underlying Adipose Tissue Dysfunction in Obesity: From Adaptive Hyperplasia to Pathological Hypertrophy
    Anna Grudniewska, Beata Mrozikiewicz-Rakowska, Kacper Wiszniewski +3
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  5. Nuclear Factor Kappa‐B Inducing Kinase‐ and Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Binding Protein Promotes Pathological Cardiac Hypertrophy by Regulating Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Mediated Nuclear Factor Kappa‐B Activation
    Zheng Xie, Yingjie Zuo, Mengyao Wang +11
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDMolecular biology & gene regulationCrossref

Cite

BibTeXRIS
BibTeX
@article{liu2026astragaloside,
  title = {{Astragaloside IV and Ferroptosis Modulation in Pathological Cardiac Hypertrophy: Current Evidence, an Integrative Hypothesis, and Future Directions}},
  author = {Pengbo Liu and Yongzhi Deng},
  journal = {Pharmacology research \& perspectives},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13675521},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Astragaloside IV and Ferroptosis Modulation in Pathological Cardiac Hypertrophy: Current Evidence, an Integrative Hypothesis, and Future Directions
AU  - Pengbo Liu
AU  - Yongzhi Deng
PY  - 2026
DA  - 2026/10/16
JO  - Pharmacology research & perspectives
UR  - https://europepmc.org/article/PMC/PMC13675521
SN  - 2052-1707
ER  -